These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11953721)

  • 1. Emergence of new pathogens in CF: the devil we know or the devil we don't know?
    Burns JL
    J Pediatr; 2002 Mar; 140(3):283-4. PubMed ID: 11953721
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibiotic prophylaxis in infants and young children with cystic fibrosis: a randomized controlled trial.
    Stutman HR; Lieberman JM; Nussbaum E; Marks MI
    J Pediatr; 2002 Mar; 140(3):299-305. PubMed ID: 11953726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CF and antistaphylococcal prophylaxis.
    Smyth A; Walters S
    Thorax; 2001 Oct; 56(10):819-20. PubMed ID: 11596571
    [No Abstract]   [Full Text] [Related]  

  • 4. Prophylactic antibiotics in cystic fibrosis: a conviction without evidence?
    Smyth A
    Pediatr Pulmonol; 2005 Dec; 40(6):471-6. PubMed ID: 16200640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On staphylococcal prophylaxis in CF.
    Wall M
    Pediatr Pulmonol; 2007 Feb; 42(2):186; author reply 187. PubMed ID: 17186506
    [No Abstract]   [Full Text] [Related]  

  • 6. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis diagnosed in a 38-year-old man with long-standing HIV infection.
    Hoyer HX; Schmid H; Gamarra F; Fischer R; Wörnle M; Huber RM
    Clin Infect Dis; 2004 Aug; 39(3):438-9. PubMed ID: 15307016
    [No Abstract]   [Full Text] [Related]  

  • 8. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
    Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E;
    Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudomonas aeruginosa and Burkholderia cenocepacia infections in patients affected by cystic fibrosis: serum resistance and antibody response.
    Savoia D; Deplano C; Zucca M
    Immunol Invest; 2008; 37(1):19-27. PubMed ID: 18214797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive group A streptococcus in two siblings: a case for antibiotic prophylaxis of close contacts.
    Husain E; Bigham M; Davies D; Daly P; Dobson S
    Can Commun Dis Rep; 2001 Sep; 27(17):141-6. PubMed ID: 11550623
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pseudomonas aeruginosa pneumonia].
    Watanabe K; Matsuyama N; Ikeda N
    Ryoikibetsu Shokogun Shirizu; 1999; (23 Pt 1):371-3. PubMed ID: 10088418
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of Bordetella spp. in respiratory specimens from individuals with cystic fibrosis.
    Spilker T; Liwienski AA; LiPuma JJ
    Clin Microbiol Infect; 2008 May; 14(5):504-6. PubMed ID: 18325036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative pneumonia after major pulmonary resections: an unsolved problem in thoracic surgery.
    Radu DM; Jauréguy F; Seguin A; Foulon C; Destable MD; Azorin J; Martinod E
    Ann Thorac Surg; 2007 Nov; 84(5):1669-73. PubMed ID: 17954082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of antibiotic prophylaxis in acute necrotizing pancreatitis].
    Rünzi M; Layer P
    Z Gastroenterol; 1996 Feb; 34(2):151-3. PubMed ID: 8659191
    [No Abstract]   [Full Text] [Related]  

  • 15. Post-operative infections in cystic fibrosis and non-cystic fibrosis patients after lung transplantation.
    Bonvillain RW; Valentine VG; Lombard G; LaPlace S; Dhillon G; Wang G
    J Heart Lung Transplant; 2007 Sep; 26(9):890-7. PubMed ID: 17845927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of staphylococcal infection in cystic fibrosis].
    Sermet-Gaudelus I
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S91-9. PubMed ID: 12910140
    [No Abstract]   [Full Text] [Related]  

  • 17. Biomarkers of neutrophilic inflammation in exhaled air of cystic fibrosis children with bacterial airway infections.
    Bodini A; D'Orazio C; Peroni D; Corradi M; Folesani G; Baraldi E; Assael BM; Boner A; Piacentini GL
    Pediatr Pulmonol; 2005 Dec; 40(6):494-9. PubMed ID: 16229003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute Pseudomonas challenge in cystic fibrosis mice causes prolonged nuclear factor-kappa B activation, cytokine secretion, and persistent lung inflammation.
    Saadane A; Soltys J; Berger M
    J Allergy Clin Immunol; 2006 May; 117(5):1163-9. PubMed ID: 16675347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burkholderia cepacia complex bacteria: opportunistic pathogens with important natural biology.
    Mahenthiralingam E; Baldwin A; Dowson CG
    J Appl Microbiol; 2008 Jun; 104(6):1539-51. PubMed ID: 18217926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consequences of combining cystic fibrosis- and non-cystic fibrosis-derived Pseudomonas aeruginosa antibiotic susceptibility results in hospital antibiograms.
    Bosso JA; Mauldin PD; Steed LL
    Ann Pharmacother; 2006 Nov; 40(11):1946-9. PubMed ID: 17018687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.